Clinical phenotypes and outcomes of severe pulmonary hypertension associated with chronic obstructive pulmonary disease
D. Montani (Paris, France), A. Diaz (Saint Etienne Cedex, France), S. Chelabi (Paris, France), X. Jais (Paris, France), L. Savale (Paris, France), M. Froudarakis (Saint Etienne Cedex, France), S. Bezzeghoud (Saint Etienne Cedex, France), A. Boucly (Paris, France), M. Jevnikar (Paris, France), O. Sitbon (Paris, France), L. Bertoletti (Saint Etienne Cedex, France), M. Humbert (Paris, France)
Source: International Congress 2022 – Non-PAH pulmonary hypertension
Session: Non-PAH pulmonary hypertension
Session type: Thematic Poster
Number: 3461
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Montani (Paris, France), A. Diaz (Saint Etienne Cedex, France), S. Chelabi (Paris, France), X. Jais (Paris, France), L. Savale (Paris, France), M. Froudarakis (Saint Etienne Cedex, France), S. Bezzeghoud (Saint Etienne Cedex, France), A. Boucly (Paris, France), M. Jevnikar (Paris, France), O. Sitbon (Paris, France), L. Bertoletti (Saint Etienne Cedex, France), M. Humbert (Paris, France). Clinical phenotypes and outcomes of severe pulmonary hypertension associated with chronic obstructive pulmonary disease. 3461
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|